TrialPanorama/TrialPanorama-database huggingface dataset:
Study NCT01082315 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT01082315 — Predictive Biomarker (PRD): KRAS mRNA
Genes: KRAS; KRAS2; RASK2
Study NCT04082819 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02656693 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05446818 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01197170 — Predictive Biomarker (PRD): Hormone receptor
Study NCT01534364 — Surrogate Endpoint (SUR): Serum creatinine
Study NCT01285908 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02163473 — Predictive Biomarker (PRD): Hypoxia-inducible factor 1-alpha
Genes: HIF1A; BHLHE78; MOP1; PASD8
Study NCT01184482 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT01184482 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT00000511 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01905358 — Safety Biomarker (SAF): Hyaluronic acid
Study NCT00437645 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03951818 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT01791712 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT01791712 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study NCT02225002 — Predictive Biomarker (PRD): CD40 mRNA
Genes: CD40; TNFRSF5
Study NCT02225002 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT01180582 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT02955030 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT01065974 — Predictive Biomarker (PRD): HFE mRNA
Genes: HFE; HLAH
Study NCT03320577 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00818701 — Safety Biomarker (SAF): B-type natriuretic peptide
Genes: NPPB
Study NCT01131195 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT02437162 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT00737815 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT03013296 — Pharmacodynamic Biomarker (PDY): Gastric inhibitory polypeptide
Genes: GIP
Study NCT00120419 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT03693157 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT02574637 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT03380299 — Predictive Biomarker (PRD): CD44 mRNA
Genes: CD44; LHR; MDU2; MDU3; MIC4
Study NCT04311086 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04374942 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT01420146 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT00430508 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00509483 — Predictive Biomarker (PRD): TG mRNA
Genes: TG
Study NCT00485368 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study NCT02074410 — Pharmacodynamic Biomarker (PDY): Huntingtin
Genes: HTT; HD; IT15
Study NCT04504552 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT01441570 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04335136 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study NCT03122834 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study NCT01489696 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01655004 — Predictive Biomarker (PRD): UGT2B17 mRNA
Genes: UGT2B17
Study NCT03144466 — Safety Biomarker (SAF): PDCD1
Genes: CD279; PD1; hSLE1; PD-1
Study NCT03675880 — Predictive Biomarker (PRD): AMD1 mRNA
Genes: AMD1; AMD
Study NCT04208178 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT04208178 — Predictive Biomarker (PRD): PIK3CA mRNA
Genes: PIK3CA
Study NCT02906176 — Predictive Biomarker (PRD): SLCO2B1 mRNA
Genes: SLCO2B1; KIAA0880; OATP2B1; OATPB; SLC21A9
Study NCT02906176 — Safety Biomarker (SAF): Cytochrome P450 2C19
Genes: CYP2C19
Study NCT00311467 — Safety Biomarker (SAF): Interleukin 2
Genes: IL2
Study NCT04958356 — Monitoring Biomarker (MOI): Tissue transglutaminase
Genes: TGM2
Study NCT01383889 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01345071 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT02238080 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT02238080 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT03777683 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT01276236 — Predictive Biomarker (PRD): CCR5 mRNA
Genes: CCR5; CMKBR5
Study NCT01110200 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT00011453 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Nqo1 mRNA
Genes: NQO1; DIA4; NMOR1
Study NCT02322450 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00325624 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00810017 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT01288092 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT01288092 — Predictive Biomarker (PRD); Safety Biomarker (SAF): PIK3CA
Genes: PI3K
Study NCT01288092 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study NCT01288092 — Predictive Biomarker (PRD): Hormone receptor
Study NCT03369145 — Predictive Biomarker (PRD): FGF21 mRNA
Genes: FGF21; UNQ3115/PRO10196
Study NCT03369145 — Predictive Biomarker (PRD): PYY mRNA
Genes: PYY
Study NCT05178875 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03146533 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT01209702 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT01209702 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT00508404 — Predictive Biomarker (PRD): KRAS mRNA
Genes: KRAS; KRAS2; RASK2
Study NCT01500356 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT01500356 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02315365 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT04708314 — Predictive Biomarker (PRD): DMD mRNA
Genes: DMD
Study NCT03291366 — Predictive Biomarker (PRD): MSC mRNA
Genes: MSC; ABF1; BHLHA22
Study NCT05066490 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Free fatty acids
Study NCT00295373 — Predictive Biomarker (PRD): TLR4 mRNA
Genes: TLR4
Study NCT00295373 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT03542786 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT04608695 — Predictive Biomarker (PRD): AMH mRNA
Genes: AMH; MIF
Study NCT04608695 — Predictive Biomarker (PRD): Phosphatase and tensin homolog
Genes: PTEN; MMAC1; TEP1
Study NCT02841371 — Surrogate Endpoint (SUR): Serum creatinine
Study NCT02841371 — Safety Biomarker (SAF): Cystatin C
Genes: CST3
Study NCT02780882 — Predictive Biomarker (PRD): POMC
Genes: MSH; POC; CLIP; ACTH; NPP; LPH
Study NCT02780882 — Surrogate Endpoint (SUR): Urine free cortisol
Study NCT03891901 — Predictive Biomarker (PRD); Safety Biomarker (SAF): White blood cell
Study NCT03674827 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT04536883 — Predictive Biomarker (PRD): ACR mRNA
Genes: ACR; ACRS
Study NCT02913456 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT03400800 — Predictive Biomarker (PRD): PCSK9 mRNA
Genes: PCSK9; NARC1; PSEC0052
Study NCT03400800 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT02543255 — Surrogate Endpoint (SUR): Pathological complete response
Study NCT01425112 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT01425112 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study NCT03491410 — Predictive Biomarker (PRD): PI3 mRNA
Genes: PI3; WAP3; WFDC14
Study NCT01776216 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00776516 — Predictive Biomarker (PRD): CYP3A4 mRNA
Genes: CYP3A4; CYP3A3
Study NCT03572556 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT03572556 — Predictive Biomarker (PRD): CXCR4 mRNA
Genes: CXCR4
Study NCT02677155 — Safety Biomarker (SAF): PDCD1
Genes: CD279; PD1; hSLE1; PD-1
Study NCT00931489 — Predictive Biomarker (PRD): RPE mRNA
Genes: RPE; HUSSY-17
Study NCT02858076 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT02858076 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study NCT01063283 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00862082 — Predictive Biomarker (PRD): AKR1C3 mRNA
Genes: AKR1C3; DDH1; HSD17B5; KIAA0119; PGFS
Study NCT01866267 — Predictive Biomarker (PRD): CCR5 mRNA
Genes: CCR5; CMKBR5
Study NCT01050400 — Safety Biomarker (SAF): Cytochrome P450 2D6
Genes: CYP2D6; CYP2DL1
Study NCT00083720 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT00083720 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT04536870 — Predictive Biomarker (PRD): GLS mRNA
Genes: GLS; GLS1; KIAA0838
Study NCT03382574 — Predictive Biomarker (PRD): BRCA1 mRNA
Genes: BRCA1; RNF53
Study NCT04083768 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01521793 — Predictive Biomarker (PRD): RPE65 mRNA
Genes: RPE65
Study NCT01521793 — Predictive Biomarker (PRD): LRAT mRNA
Genes: LRAT
Study NCT02897479 — Predictive Biomarker (PRD): Proto-oncogene c-Met
Genes: MET
Study NCT01518764 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01420211 — Safety Biomarker (SAF): SLCO1B1
Genes: OATP-C; LST-1; OATP1B1
Study NCT01420211 — Predictive Biomarker (PRD): SLCO1B3 mRNA
Genes: SLCO1B3; LST2; OATP1B3; OATP8; SLC21A8
Study NCT02727335 — Predictive Biomarker (PRD): ALK tyrosine kinase receptor
Genes: ALK
Study NCT01265524 — Surrogate Endpoint (SUR): Serum potassium
Study NCT02667080 — Surrogate Endpoint (SUR): Sperm parameters
Study NCT02093819 — Predictive Biomarker (PRD): CYP2C9 mRNA
Genes: CYP2C9; CYP2C10
Study NCT00500682 — Surrogate Endpoint (SUR): Serum creatinine
Study NCT02964169 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT00980174 — Predictive Biomarker (PRD): TNFRSF11A mRNA
Genes: TNFRSF11A; RANK
Study NCT00980174 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT02747797 — Predictive Biomarker (PRD): PDGFRB mRNA
Genes: PDGFRB; PDGFR; PDGFR1
Study NCT02747797 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT02747797 — Pharmacodynamic Biomarker (PDY): Fibroblast growth factor receptor
Study NCT02747797 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study NCT02348515 — Predictive Biomarker (PRD): ACE2 mRNA
Genes: ACE2; UNQ868/PRO1885
Study NCT02348515 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study NCT00003439 — Safety Biomarker (SAF): Interleukin 12
Study NCT03586557 — Predictive Biomarker (PRD): AQP4 mRNA
Genes: AQP4
Study NCT03509519 — Predictive Biomarker (PRD); Monitoring Biomarker (MOI): BDNF mRNA
Genes: BDNF
Study NCT03509519 — Safety Biomarker (SAF): BDNF
Study NCT03682497 — Surrogate Endpoint (SUR): Serum potassium
Study NCT04665011 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00925925 — Predictive Biomarker (PRD): CD5 mRNA
Genes: CD5; LEU1
Study NCT00925925 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT01227902 — Pharmacodynamic Biomarker (PDY): Valproic acid
Study NCT02831673 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT00874120 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04425018 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT00731874 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04415476 — Surrogate Endpoint (SUR): Forced vital capacity
Study NCT01482364 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02002975 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02811497 — Predictive Biomarker (PRD): Programmed cell death 1 ligand 1
Genes: CD274; B7H1; PDCD1L1; PDCD1LG1; PDL1
Study NCT02811497 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT02811497 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study NCT03944252 — Safety Biomarker (SAF): PDCD1
Genes: CD279; PD1; hSLE1; PD-1
Study NCT04189406 — Predictive Biomarker (PRD): AMH mRNA
Genes: AMH; MIF
Study NCT00101257 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT01446484 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT02386722 — Predictive Biomarker (PRD): Exhaled nitric oxide
Study NCT01714609 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02172040 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04541459 — Surrogate Endpoint (SUR): Sperm parameters
Study NCT01874171 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT01951469 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT02605460 — Predictive Biomarker (PRD): CXCR4 mRNA
Genes: CXCR4
Study NCT03727724 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT00174486 — Predictive Biomarker (PRD): PDE5A mRNA
Genes: PDE5A; PDE5
Study NCT03757741 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT03757741 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT00005810 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT01646125 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT04737902 — Predictive Biomarker (PRD): CNP mRNA
Genes: CNP
Study NCT01904903 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT03307876 — Predictive Biomarker (PRD): A2M mRNA
Genes: A2M; CPAMD5; FWP007
Study NCT04247659 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Endothelin-1
Genes: EDN1
Study NCT04624503 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT00159289 — Predictive Biomarker (PRD): Exhaled nitric oxide
Study NCT02108405 — Predictive Biomarker (PRD): CD27 mRNA
Genes: CD27; TNFRSF7
Study NCT04136275 — Predictive Biomarker (PRD): CD37 mRNA
Genes: CD37; TSPAN26
Study NCT00478699 — Predictive Biomarker (PRD): BRCA1 mRNA
Genes: BRCA1; RNF53
Study NCT02450487 — Predictive Biomarker (PRD): CYP2C9 mRNA
Genes: CYP2C9; CYP2C10
Study NCT04675008 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT04675008 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT00459732 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT04075045 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02074462 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT02991092 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT00580528 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02312531 — Monitoring Biomarker (MOI): HBV DNA
Study NCT04141904 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT03655925 — Safety Biomarker (SAF): Human leucocyte antigen
Study NCT02645175 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT02980510 — Predictive Biomarker (PRD): RAF1 mRNA
Genes: RAF1; RAF
Study NCT04952948 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02066272 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT00839319 — Surrogate Endpoint (SUR): Serum testosterone
Study NCT02430103 — Predictive Biomarker (PRD): AMH mRNA
Genes: AMH; MIF
Study NCT00774384 — Surrogate Endpoint (SUR): Serum bactericidal antibody
Study NCT02787733 — Safety Biomarker (SAF): Reactive oxygen species
Study NCT00852293 — Predictive Biomarker (PRD); Monitoring Biomarker (MOI): Chitinase-3-like protein 1
Genes: CHI3L1
Study NCT00138736 — Predictive Biomarker (PRD): MBL2 mRNA
Genes: MBL2; COLEC1; MBL
Study NCT01712308 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study NCT01970098 — Predictive Biomarker (PRD): SCD mRNA
Genes: SCD; FADS5; SCD1; SCDOS
Study NCT02758795 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT02758795 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT00755638 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study NCT04322786 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study NCT02197078 — Pharmacodynamic Biomarker (PDY): Dipeptidyl peptidase 4
Genes: DPP4; ADCP2; CD26
Study NCT00304941 — Predictive Biomarker (PRD): BRCA1 mRNA
Genes: BRCA1; RNF53
Study NCT00304941 — Predictive Biomarker (PRD): BRCA2 mRNA
Genes: BRCA2; FACD; FANCD1
Study NCT01910935 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01409603 — Pharmacodynamic Biomarker (PDY): Blood coagulation
Study NCT04499105 — Predictive Biomarker (PRD): MSC mRNA
Genes: MSC; ABF1; BHLHA22
Study NCT03104725 — Pharmacodynamic Biomarker (PDY): Cysteinyl dopamine
Study NCT01358903 — Predictive Biomarker (PRD): CD44 mRNA
Genes: CD44; LHR; MDU2; MDU3; MIC4
Study NCT03231709 — Pharmacodynamic Biomarker (PDY): Dipeptidyl peptidase 4
Genes: DPP4; ADCP2; CD26
Study NCT00133094 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT02608801 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT01753908 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Nqo1 mRNA
Genes: NQO1; DIA4; NMOR1
Study NCT01753908 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study NCT00215605 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor receptor 2
Genes: KDR; FLK1; VEGFR2
Study NCT00215605 — Predictive Biomarker (PRD): Proto-oncogene c-Met
Genes: MET
Study NCT00215605 — Predictive Biomarker (PRD): RET mRNA
Genes: RET; CDHF12; CDHR16; PTC; RET51
Study NCT00441064 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04306861 — Predictive Biomarker (PRD): SMAD4 mRNA
Genes: SMAD4; DPC4; MADH4
Study NCT03198325 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT04049149 — Predictive Biomarker (PRD): CP mRNA
Genes: CP
Study NCT04668170 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT04668170 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT04446364 — Surrogate Endpoint (SUR): Bacterial count
Study NCT03639909 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study NCT03639909 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01219283 — Predictive Biomarker (PRD): PGD mRNA
Genes: PGD; PGDH
Study NCT03233178 — Predictive Biomarker (PRD): SLC5A2 mRNA
Genes: SLC5A2; SGLT2
Study NCT04293822 — Predictive Biomarker (PRD): AGA mRNA
Genes: AGA
Study NCT03238495 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT03238495 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT02347657 — Predictive Biomarker (PRD): CFTR mRNA
Genes: CFTR; ABCC7
Study NCT02347657 — Predictive Biomarker (PRD): CFTR
Genes: MRP7; ABC35; TNR-CFTR; dJ760C5.1; CFTR/MRP
Study NCT03111628 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Immunoglobulin E
Study NCT04482543 — Predictive Biomarker (PRD): PVR mRNA
Genes: PVR; PVS
Study NCT01075906 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT02397629 — Surrogate Endpoint (SUR): Serum calcium
Study NCT00286676 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT00286676 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT04525105 — Predictive Biomarker (PRD): Mothers against decapentaplegic homolog 2
Genes: SMAD2; MADH2; MADR2
Study NCT04525105 — Predictive Biomarker (PRD): SMAD3 mRNA
Genes: SMAD3; MADH3
Study NCT02440841 — Predictive Biomarker (PRD): CYP3A4 mRNA
Genes: CYP3A4; CYP3A3
Study NCT03643068 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT03643068 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT03643068 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT01450423 — Predictive Biomarker (PRD); Monitoring Biomarker (MOI): BDNF mRNA
Genes: BDNF
Study NCT01450423 — Safety Biomarker (SAF): BDNF
Study NCT03980093 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study NCT04274946 — Predictive Biomarker (PRD): SLN mRNA
Genes: SLN
Study NCT03091348 — Surrogate Endpoint (SUR): Serum testosterone
Study NCT00502034 — Safety Biomarker (SAF): Interleukin 2
Genes: IL2
Study NCT00051519 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT01533350 — Predictive Biomarker (PRD): LIF mRNA
Genes: LIF; HILDA
Study NCT01533350 — Pharmacodynamic Biomarker (PDY): Matrix metalloproteinase 9
Genes: MMP9; CLG4B